Cargando…
Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease
The discovery of the D3 receptor (D3R) subtypes of dopamine (DA) has generated an understandable increase in interest in the field of neurological diseases, especially Parkinson’s disease (PD). Indeed, although DA replacement therapy with l-DOPA has provided an effective treatment for patients with...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961531/ https://www.ncbi.nlm.nih.gov/pubmed/35204744 http://dx.doi.org/10.3390/biom12020243 |